-
Deborah Sims
#CLL patient interviews one of her doctors Prof John Gribben who gives a great overview from#ASH2019.@JanRynne@annemarieMurphE@CllSocietyhttps://youtu.be/xTWQsWlQjL8 -
Neste vídeo conversamos com o Dr. Jacques Tabacof , durante o ASH Annual Meeting a respeito das novidades apresentadas sobre o CART-Cell. Confira
http://bit.ly/2NNiGTh #ASH2019#CARTCell#câncer#hematologiapic.twitter.com/bjsGWFlmyr
-
Neste vídeo conversamos com o Dr. Angelo Maiolino, durante o ASH Annual Meeting (maior congresso de hematologia do mundo) sobre as novidades apresentadas para os pacientes de Mieloma Múltiplo. Confira
http://bit.ly/34nasqp #ASH2019#mielomamúltiplo#câncer#hematologiapic.twitter.com/FdwgGynUZc
-
In case you were not able to attend
#ASH2019 ASH 2019 MPN Updates - Myelofibrosis and IMG-7289 https://youtu.be/f3QNYFjCPq0 via@YouTube -
So many advantages from phase I clinical trials! Dr Francesc Bosch
@Hemato_Vhebron @Sidnavigare points them all out in#ASH2019 https://youtu.be/Sja5YE6s2Vg -
To find out more about
#TelomereBiologyDisorders onsite at#ASH2019 go and speak to our#advocacy partners@TeamTelomereInc! Or watch this fantastic video they createdhttps://www.youtube.com/watch?v=vS8luPpYJAY … -
Lymphoma Australia are at
#ASH2019 interviewing the lymphoma experts about the latest updates to inform lymphoma & CLL patients.@lymphomaOz Meet the team -https://youtu.be/P7heXY9J1_A -
#ASH2019 I take home messages di Francesco Merli per i linfomi recidivanti plurirefrattari: oggi nuove opzioni#lymsm@StefanoLuminari@frbertoni@gloria_iacoboni@e_campagnaro@PaolaGhione_MD@snovellicpic.twitter.com/CQ01NX40t8 – mjesto: Orange County Convention Center (OCCC) -
-
#ASH2019@MikkaelSekeres I published a case series of 2 pts which you should have included
.
#traineedidacticsession. How to give a talkpic.twitter.com/Pq4Fl02Of6 -
Good morning
#ash2019 stop by my poster and learn about the impact of diagnosis to treatment interval on the outcome of patients with AML#leusm@GWCancer@MedStarGUH#washingtonDcpic.twitter.com/wMOo0ubZ9C -
If you missed Dr. Stadtmauer’s presentation this morning at
#ASH19, here is a quick recap of the early results from the first-in-U.S. use of#CRISPR edited immune cells to treat cancer.@PennCancer@PennMedicine w/ @parkerici & @TmunityTx#ASH2019 pic.twitter.com/0kicLGKsIn -
-
We have a fantastic weekend ahead of us at
#ASH2019
Take a look at what we have lined up! 
Follow @CTRUmyeloma for updates!@ASH_hematology#CancerResearch#Myeloma#SeeYouTherepic.twitter.com/iZdgh6DgDG -
"Dr. Mailankody on BCMA CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma" https://youtu.be/W7U4hR4iq8Y via
@OncLive#ASH19#ASH2019 -
We're going to
#ASH2019
Here is what we have in store for you all @ASH_hematology#Myeloma#CancerResearch#Presentations#ComeSayHi!@kennycairns@profBigG@profghjackson@MyMKaiser@_DrCPpic.twitter.com/wjeogZEzQ1 -
Not long to go until
#ASH2019 ! Set to be a great few days!
@ASH_hematology#watchthisspace#SeeYouThere!pic.twitter.com/5UaoUwmoC9 -
@MorphoSys is looking forward to be at#ASH2019 in Orlando – come and visit us at booth #1261 View our abstracts accepted for presentation on#tafasitamab at#ASH2019 -> http://www.bit.ly/2DGpDQK#ash2019#oncology#biopharma#morphosys#biotechnology#DLBCL#bloodcancerpic.twitter.com/BO5eVUkkmG
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.